Xone Ceff S 1000mg/500mg Injection is a sterile, injectable formulation combining Ceftriaxone, a third-generation cephalosporin antibiotic, and Sulbactam, a beta-lactamase inhibitor. Ceftriaxone exhibits broad-spectrum bactericidal activity by inhibiting bacterial cell wall synthesis, effective against a wide range of Gram-positive and Gram-negative pathogens. Sulbactam enhances the efficacy of Ceftriaxone by irreversibly binding to and inhibiting beta-lactamase enzymes produced by resistant bacteria, thereby preventing antibiotic degradation. This combination is indicated for the treatment of various infections including lower respiratory tract infections, urinary tract infections, skin and soft tissue infections, intra-abdominal infections, septicemia, and meningitis caused by susceptible organisms. Xone Ceff S is administered via intramuscular or intravenous injection, with dosage and duration tailored to the severity and type of infection, as well as patient-specific factors such as renal function. The combination is generally well tolerated; however, hypersensitivity reactions, gastrointestinal disturbances, and local injection site reactions may occur. Caution is advised in patients with known penicillin or cephalosporin allergy. This formulation provides an effective therapeutic option for managing infections caused by beta-lactamase producing bacteria, improving clinical outcomes in resistant infections.